LabHealth
Machine-learning model estimates overactive-bladder risk in women
Researchers trained the model on 7,884 participants from a US health survey covering 2011–2018.
Written by AI1 source2 min
Loading…
Diagnostics, prosthetics, vaccines, genomics: the medicine that adds years to a life.
Medicine that wins years of life: AI-assisted screening examining millions of patients, next-generation vaccines, genomics moving from sequencing to treatment, prosthetics and implants restoring lost abilities. The section follows completed clinical trials, market authorisations, hospital roll-outs — the moment a technology stops being a paper and becomes care.
The numbers rule: cohorts, detection rates, avoided mortality, costs. We gladly cover the health systems deploying at scale — India, Brazil, Southeast Asia — because frugal technologies often prove themselves there before arriving anywhere else. Every article rests on the trial, authorisation or study behind it, and cites them.
Researchers trained the model on 7,884 participants from a US health survey covering 2011–2018.
The result is limited to cell cultures; mouse tests of tumor injections are being pursued.
NTU and UIUC scanned people at 7T while they weighed stakes, acted, and assessed outcomes.
Julie Kim’s team used patient-derived iPSCs to make stromal cells carrying endometriosis-linked biology.
The ASPIRE phase 1/2 trial tested four targeted drugs in 29 previously untreated patients.
Washington University researchers developed NGSE-Corr to compare imaging tools when the true measurement is unknown.
Risca's team tracked liposarcoma and ER-positive breast cancer cells for nearly a month.
A six-month UIC trial assigned 32 adults to time-restricted eating, calorie reduction or no dietary change.
Sanford Burnham Prebys researchers identified Firefox and Honeybadger as opposing regulators of MYC-driven tumors.
Researchers at Birmingham and UCL compared 82 ultrasound detectors used in photoacoustic imaging.
A three-week program helped patients retain everyday abilities better than usual unstructured rehabilitation.
Yonsei researchers analyzed oral microbes from 507 volunteers, including people with gastric and colorectal cancer.
ASU researchers studied 8,687 blood samples from 4,089 people across healthy and immunosuppressed groups.
Monash University developed living kidney organoids that reproduce key features of human acute kidney injury.
The trial covered 20 Colombian urban areas, each with around 1,600 to 2,000 households.
The combination outperformed either treatment alone in a preclinical female-rodent model.
It targets BCL6, which normally silences genes that can stop growth or trigger programmed cell death.
An Australian team screened 63 existing medicines in patient-derived brain cells.